Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote population

BMJ Open

Volumn 6, Issue 10, 2016, Pages

  Jumah, Naana Afua ^a   Edwards, Craig ^b   Balfour Boehm, Jazmyn ^a   Loewen, Kassandra ^c   Dooley, Joseph ^d   Finn, Lianne Gerber ^d   Kelly, Len ^c  

^a NORTHERN ONTARIO SCHOOL OF MEDICINE   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c Anishinaabe Bimaadiziwin Research Unit   (Canada)

^d Sioux Lookout Meno Ya Win Health Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE PLUS NALOXONE; HYDROMORPHONE; MORPHINE; OXYCODONE; BUPRENORPHINE; NALOXONE; NARCOTIC ANTAGONIST;

ADULT; ALCOHOL CONSUMPTION; APGAR SCORE; ARTICLE; BIRTH WEIGHT; CANNABIS USE; CESAREAN SECTION; CLEFT PALATE; COCAINE DEPENDENCE; COHORT ANALYSIS; CONGENITAL MALFORMATION; CONTROLLED STUDY; DRUG SAFETY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HEART ATRIUM SEPTUM DEFECT; HEPATITIS C; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; NEONATAL ABSTINENCE SYNDROME; OBSERVATIONAL STUDY; ONTARIO; OPIATE ADDICTION; POSTPARTUM HEMORRHAGE; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; RETROSPECTIVE STUDY; RURAL AREA; SIDE EFFECT; SMOKING; STILLBIRTH; THIRD TRIMESTER PREGNANCY; CHEMICALLY INDUCED; ETHNOLOGY; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; PREGNANT WOMAN; PSYCHOLOGY; RURAL POPULATION; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ADULT; APGAR SCORE; BIRTH WEIGHT; BUPRENORPHINE; FEMALE; HUMANS; INFANT, NEWBORN; NALOXONE; NARCOTIC ANTAGONISTS; NEONATAL ABSTINENCE SYNDROME; ONTARIO; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANT WOMEN; RETROSPECTIVE STUDIES; RURAL POPULATION; TREATMENT OUTCOME;

EID: 84994644653     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2016-011774     Document Type: Article

References (23)

1. Dooley R, Dooley J, Antone I, et al. Narcotic tapering in pregnancy using long-Acting morphine: An 18 month year prospective study in Northwest Ontario. Can Fam Physician 2015;61:e88-95.
2. Walker R, Cromarty H, Kelly L, et al. Achieving Cultural Safety in Aboriginal Health Services: implementation of a cross-cultural safety model in a hospital setting. Divers Health Care 2009;6:11-22.
3. Jones HE, Martin PR, Heil SH, et al. Treatment of opioid-dependent pregnant women: clinical and research issues. J Subst Abuse Treat 2008;35:245-59.
4. Winklbaur B, Kopf N, Ebner N, et al. Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: A knowledge synthesis for better treatment for women and neonates. Addiction 2008;103:1429-40.
5. Katt M, Chase C, Samokhvalov A, et al. Feasibility and outcomes of a community-based taper-To-low-dose-maintenance suboxone treatment program for prescription opioid dependence in a remote First Nations community in Northern Ontario. J Aborig Health 2012;9:52-9.
6. World Health Organization. Guidelines for the identification and management of substance use and substance use disorders in pregnancy. Geneva, Switzerland: World Health Organization, 2014:14.
7. Wong S, Ordean A, Kahan M. Substance abuse in pregnancy. J Obstet Gynaecol Can 2011;33:367-84.
8. American College of Obstetricians and Gynecologists. Opioid abuse, dependence and addiction in pregnancy. Committee opinion 524. Obstet Gynecol 2012;119:1070-1.
9. Jones HE, Kaltenbach K, Heil SH, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med 2010;363:2320-31.
10. Daily Med. Suboxone tablet (product monograph). Bethesda (MD): National Institutes of Health, 2013. http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4b9b43c4-293e-4323-A1a1-9a2f6a16ac39 (accessed 23 Aug 2013).
11. Daily Med. Suboxone soluble film (product monograph). Bethesda (MD): National Institutes of Health, 2013. http://dailymed.nlm.nih.gov/dailymed/lookup.cfm? setid=8a5edcf9-828c-4f97-b671-268ab13a8ecd (accessed 23 Aug 2013).
12. Rementeriá JL, Nunag NN. Narcotic withdrawal in pregnancy: stillbirth incidence with a case report. Am J Obstet Gynecol 1973;116:1152-6.
13. Stern R. The pregnant addict: A study of 66 case histories, 1950-1959. Am J Obstet Gynecol 1966;94:253-7.
14. Daily Med. Naloxone hydrochloride (product monograph). Bethesda (MD): National Institutes of Health, 2013. http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d524c0e5-A7c2-40b2-9eed-2caf71c787dc (accessed 23 Aug 2013).
15. Food and Drug Administration. Reviewer guidance evaluating the risks of drug exposure in human pregnancies. Rockville (MD): Food and Drug Administration, 2005:4.
16. Indigenous and Northern Affairs Canada. Aboriginal women in Canada: A statistical profile from the 2006 census. Ottawa (ON): Government of Canada, 2012. https://www.aadnc-Aandc.gc.ca/eng/1331664678840/1331838092221
17. Porter CJ, Feldt RH, Edwards WD, et al. Chapter 27: Atrial septal defects. In: Allen HD, Gutgesell HP, Clark EB et al. eds. Moss & Adams heart disease in infants, children & adolescents: including the fetus and young adults. 8th edn. Philadelphia (PA): Lippincott, Williams and Wilkins, 2013 (accessed 29 May 2016).
18. Kelly L, Guilfoyle J, Dooley J, et al. incidence of narcotic abuse during pregnancy in Northwestern Ontario: Three-year prospective cohort study. Can Fam Physician 2014;60:e493-8.
19. Debelak K, Morrone WR, OGrady KE, et al. Buprenorphine +naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data. Am J Addict 2013;22:252-4.
20. Lund IO, Fisher G, Welle-Strand G, et al. A Comparison of buprenorphine+naloxone to buprenorphine and methadone in the treatment of opioid dependence during pregnancy: maternal and neonatal outcomes. Subst Abuse 2013;7:61-74.
21. Wiegand SL, Stringer EM, Stuebe AM, et al. Buprenorphine and naloxone compared with methadone treatment in pregnancy. Obstet Gynecol 2015;125:363-8.
22. Mattick RP, Breen C, Kimber J, et al. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2014;(2):CD002207.
23. Jumah NA, Graves L, Kahan M. The management of opioid dependence in pregnancy in rural and remote settings. CMAJ 2015;187:E41-6.